Jason M. Meggs - 30 Jun 2021 Form 4 Insider Report for Syneos Health, Inc.

Role
Chief Financial Officer
Signature
/s/ Sara Epstein, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
30 Jun 2021
Net transactions value
-$219,377
Form type
4
Filing time
02 Jul 2021, 17:04:46 UTC
Next filing
07 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Options Exercise $89,255 +2,068 +3.4% $43.16 62,769 30 Jun 2021 Direct F1
transaction SYNH Class A Common Stock Sale $186,120 -2,068 -3.3% $90.00 60,701 30 Jun 2021 Direct F1
transaction SYNH Class A Common Stock Options Exercise $111,488 +2,600 +4.3% $42.88 63,301 30 Jun 2021 Direct F1
transaction SYNH Class A Common Stock Sale $234,000 -2,600 -4.1% $90.00 60,701 30 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SYNH Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -2,600 -100% $0.000000* 0 30 Jun 2021 Class A Common Stock 2,600 $42.88 Direct F2
transaction SYNH Stock Option (Right to Buy Class A Common Stock) Options Exercise $0 -2,068 -98% $0.000000 40 30 Jun 2021 Class A Common Stock 2,068 $43.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
F2 The shares subject to this option vested in four approximately equal annual installments on January 19, 2017; January 19, 2018; January 19, 2019; and January 19, 2020.
F3 The shares subject to this option vested in four approximately equal annual installments on July 29, 2016; July 29, 2017; July 29, 2018; and July 29, 2019.